Oxacillins - A brief review;Oxacilline: Eine kurze übersicht

Chemotherapie Journal

Volumn 14, Issue 2, 2005, Pages 35-37

  Shah, Pramod M ^a,b  

^a Medizinische Klinik III ^*

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Dicloxacillin; Flucloxacillin; Oxacillin; Toxicity

Indexed keywords

CLOXACILLIN; DICLOXACILLIN; FLUCLOXACILLIN; METICILLIN; NAFCILLIN; OXACILLIN; PENICILLIN G;

ANTIBIOTIC THERAPY; BLOOD CELL COUNT; BONE MARROW DEPRESSION; DRUG ACTIVITY; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; INFECTION; LIVER FUNCTION TEST; LIVER METABOLISM; LIVER TOXICITY; NEUTROPENIA; RASH; RISK BENEFIT ANALYSIS; SHORT SURVEY; SIDE EFFECT; STAPHYLOCOCCUS INFECTION; THROMBOCYTOPENIA;

EID: 17744395753     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Bergan T, Engeset A, Olszewski W. Does serum protein binding inhibit tissue penetration of antibiotics? Rev Infect Dis 1987;9:713-8.
2. Bryskier A. Pénicillines. In: Bryskier A (editor). Antibiotiques, agents antibactériens et antifongiques. Paris: Ellipses Edition, 1999:157-224.
3. Bush K. Beta-lactam antibiotics: penicillins. In: Finch RG, et al. Antibiotic and Chemotherapy - antiinfective agents and their use in therapy. Edinburgh: Churchill-Livingstone 2003;8:224-58.
4. Fairley CK, McNeil JJ, Desmond P, et al. Risk factors for development of flucloxacillin associated jaundice. BMJ 1993;306:233-5.
5. Hautekeete ML. Hepatotoxicity of antibiotics. Acta Gastroenterol Belg 1995;LVIII:290-6.
6. Huppertz K, Wiedemann B. GENARS-Resistenzstatistik. Chemother J 2002;11:148-50.
7. Kresken M, Hafner D, Witte W, et al. Resistenzentwicklung bei Staphylokokken und anderen grampositiven Erregern gegenüber Chemotherapeutika im mitteleuropäischen Raum. Chemother J 2000;9:5-14.
8. Maraqa NF, Gomez MM, Rathore MH, et al. Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials. Clin Infect Dis 2002;34:50-4.
9. Plempel M, Otten H, Heilmeyer W. Antibiotika Fibel. Stuttgart: Georg-Thieme-Verlag 1969.
10. Rosenthal EJK. Antibiotika-Empfindlichkeit von Sepsis-Erregern 2000-2001. Chemother J 2003;12:71-8.
11. Schulthess HK, Neftel KA, Gatell JM, et al. Die Inzidenz der Penicillin-Nebenwirkungen ist dosisabhängig. ZAC Z Antimikrob Antineoplast Chemother 1984:2-4:223-30.
12. Simon C, Stille W. Antibiotika-Therapie in Klinik und Praxis. Stuttgart: Schattauer 2000.